🇺🇸 FDA
Patent

US 12257325

Chelating platform for delivery of radionuclides

granted A61KA61K51/0478A61K51/0482

Quick answer

US patent 12257325 (Chelating platform for delivery of radionuclides) held by The Regents of the University of California expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K51/0478, A61K51/0482, A61P, A61P35/00